Search Results

HIV PrEP | Pep Coll, MD

HIV PrEP | Pep Coll, MD

Long acting HIV drugs for prevention: what are the data? | Pep Coll, MD

Long acting HIV drugs for prevention: what are the data? | Pep Coll, MD

Challenges of Long-Term PrEP | Pep Coll, MD

Challenges of Long-Term PrEP | Pep Coll, MD

The Role of Integrase Inhibitors during HIV prevention | Pep Coll, MD

The Role of Integrase Inhibitors during HIV prevention | Pep Coll, MD

HIV prevention and the role of integrase inhibitors | Pep Coll, MD

HIV prevention and the role of integrase inhibitors | Pep Coll, MD

PrEP Rollout in Europe: Current Update - Pep Coll

PrEP Rollout in Europe: Current Update - Pep Coll

Long term impacts of PrEP – How to reduce toxicity and resistance - Pep Coll, MD

Long term impacts of PrEP – How to reduce toxicity and resistance - Pep Coll, MD

The current status of PrEP in Europe | Pep Coll, MD

The current status of PrEP in Europe | Pep Coll, MD

Roadblocks to implementation | Pep Coll, MD

Roadblocks to implementation | Pep Coll, MD

Non-Occupational Post-Exposure Prophylaxis (nPEP) Guidance

Non-Occupational Post-Exposure Prophylaxis (nPEP) Guidance

Social and Logistical Barriers to Implementation of PrEP in Europe: Southern Europe | Pep Coll, MD

Social and Logistical Barriers to Implementation of PrEP in Europe: Southern Europe | Pep Coll, MD

NEMUS Webinar Series # 29:"Access to PrEP in Spain: Challenges and Ongoing Efforts"

NEMUS Webinar Series # 29:"Access to PrEP in Spain: Challenges and Ongoing Efforts"